1028291-66-8
Chemical Structure
BC-7013
- CAS No.: 1028291-66-8
- Formula:C29H40O5S
- Molecular Weight:500.69
IUPAC Name: (3aR,4R,5R,7S,8S,9R,9aS,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((3-(hydroxymethyl)phenyl)thio)acetate
InChIKey: KELRBTWVTDHIHS-KGTFJIFRSA-N
SMILES: O=C(CSC1=CC=CC(CO)=C1)O[C@H]2[C@]3(C)[C@@H](CC[C@]4([C@H]([C@@H]([C@](C=C)(C2)C)O)C)[C@@]3([H])C(CC4)=O)C
Biological Activity: BC-7013 is a novel semi-synthetic pleuromutilin derivative. BC-7013 has excellent activity against Gram-positive pathogenic bacteria. BC-7013 exhibits potent antibacterial properties against both Staphylococcus, Streptococcus and penicillin-resistant Streptococcus pneumoniae. BC-7013 has activity against Gram-positive pathogenic bacteria, BC-7013 is useful in the research of acute bacterial skin and skin structure infection (ABSSSI)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BC-7013 | 99.04% | BC-7013 is a novel semi-synthetic pleuromutilin derivative. BC-7013 has excellent activity against Gram-positive pathogenic bacteria. BC-7013 exhibits potent antibacterial properties against both Staphylococcus, Streptococcus and penicillin-resistant Streptococcus pneumoniae. BC-7013 has activity against Gram-positive pathogenic bacteria, BC-7013 is useful in the research of acute bacterial skin and skin structure infection (ABSSSI). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
